SXTC
NASDAQChina SXT Pharmaceuticals
$2.83
+1.58 (+126.40%)
Income Statement
Total Revenue
In Millions USDNet Income
In Millions USDProfit Margins
Gross
Operating
Net
Detailed Income Statement
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $2M | $2M | $2M | $3M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | $-7M | $-3M | $-3M | $-6M | $-5M |
| Net Income | $-6M | $-3M | $-3M | $-6M | $-6M |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance sheet data not available for this ticker.
Cash flow data not available for this ticker.